Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Intangibles (2019 - 2025)

Silence Therapeutics' Intangibles history spans 6 years, with the latest figure at $288000.0 for Q4 2025.

  • For Q4 2025, Intangibles fell 7.69% year-over-year to $288000.0; the TTM value through Dec 2025 reached $288000.0, down 7.69%, while the annual FY2025 figure was $288000.0, 7.69% down from the prior year.
  • Intangibles for Q4 2025 was $288000.0 at Silence Therapeutics, down from $300000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $375337.1 in Q4 2022 and bottomed at $32352.3 in Q4 2021.
  • The 5-year median for Intangibles is $311000.0 (2024), against an average of $285897.1.
  • The largest annual shift saw Intangibles tumbled 77.1% in 2021 before it surged 1060.16% in 2022.
  • A 5-year view of Intangibles shows it stood at $32352.3 in 2021, then soared by 1060.16% to $375337.1 in 2022, then dropped by 6.09% to $352487.1 in 2023, then decreased by 11.49% to $312000.0 in 2024, then decreased by 7.69% to $288000.0 in 2025.
  • Per Business Quant, the three most recent readings for SLN's Intangibles are $288000.0 (Q4 2025), $300000.0 (Q3 2025), and $317000.0 (Q2 2025).